MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-20-2026
Milestone Pharmaceuticals PEG Ratio 2011-2026 | MIST
Annual PEG Ratio Milestone Pharmaceuticals
| 2025 | 2024 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.102 | 0.0885 | - | -0.244 | 0.0245 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.102 | -0.244 | -0.00737 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
Aligos Therapeutics
ALGS
|
0.0282 | $ 8.59 | 7.44 % | $ 84.9 M |  USA |
 |
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.66 | -1.48 % | $ 8.81 B |  Australia |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M |  China |
 |
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 21.43 | 5.2 % | $ 1 B | USA |
 |
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | USA |
 |
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
1.02 | $ 1.47 | 4.64 % | $ 378 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | USA |
 |
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | USA |
 |
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.05 | 4.28 % | $ 5.02 M |  Israel |
 |
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.2 | 2.94 % | $ 449 M | USA |
 |
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 24.1 | -0.45 % | $ 3.07 B | USA |
 |
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | USA |
 |
Celldex Therapeutics
CLDX
|
1.27 | $ 32.61 | 1.15 % | $ 2.17 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.47 | -1.34 % | $ 391 M | Britain |
 |
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | Canada |
 |
Cidara Therapeutics
CDTX
|
-0.00298 | - | - | $ 1.41 B | USA |
 |
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | Israel |
 |
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B | Britain |
 |
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | USA |
 |
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | USA |
 |
Akari Therapeutics, Plc
AKTX
|
13.5 | $ 4.1 | 4.59 % | $ 276 B | Britain |
 |
Allena Pharmaceuticals
ALNA
|
-0.0713 | - | 3.16 % | $ 1.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
0.799 | $ 2.23 | 2.53 % | $ 464 M | USA |
 |
Evogene Ltd.
EVGN
|
-1.63 | $ 0.79 | -2.54 % | $ 27.9 M | Israel |
 |
Baudax Bio
BXRX
|
0.00122 | - | 0.59 % | $ 63 K | USA |
 |
Cabaletta Bio
CABA
|
-0.01 | $ 3.23 | 3.19 % | $ 325 M | USA |
 |
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B | USA |
 |
CymaBay Therapeutics
CBAY
|
-24.1 | - | - | $ 3.45 B | USA |
 |
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M | USA |